Oruka Therapeutics, Inc. short interest in 2021
In 2021, Oruka Therapeutics, Inc.'s disclosed short interest ran from 0.87% of shares outstanding on 15 Jan 2021 to 2.20% on 31 Dec 2021, a change of +1.33 percentage points. The year's high was 3.86% on 15 Apr 2021 and its low 0.87% on 15 Jan 2021, averaging 2.56% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.95 days on 31 Aug 2021. Full history: Oruka Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 0.87% (15 Jan 2021)
- End of year
- 2.20% (31 Dec 2021)
- Change
- +1.33 pp
- High
- 3.86% (15 Apr 2021)
- Low
- 0.87% (15 Jan 2021)
- Average
- 2.56%
- Highest days to cover
- 3.95 (31 Aug 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 0.87% | 1.00 | |
| 12 Feb 2021 | 1.28% | 1.00 | |
| 26 Feb 2021 | 2.12% | 1.00 | |
| 15 Mar 2021 | 3.48% | 1.00 | |
| 31 Mar 2021 | 3.27% | 1.00 | 10-K filed, results (8-K) |
| 15 Apr 2021 | 3.86% | 2.23 | |
| 30 Apr 2021 | 2.63% | 1.17 | |
| 14 May 2021 | 3.28% | 1.22 | 10-Q filed, results (8-K) |
| 28 May 2021 | 2.24% | 2.74 | |
| 15 Jun 2021 | 1.66% | 1.24 | |
| 30 Jun 2021 | 2.34% | 2.29 | |
| 15 Jul 2021 | 2.67% | 1.03 | |
| 30 Jul 2021 | 3.11% | 1.00 | |
| 13 Aug 2021 | 2.84% | 1.89 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 2.80% | 3.95 | |
| 15 Sep 2021 | 2.70% | 3.56 | |
| 30 Sep 2021 | 2.20% | 3.23 | |
| 15 Oct 2021 | 2.06% | 2.49 | |
| 29 Oct 2021 | 2.03% | 1.00 | |
| 15 Nov 2021 | 3.13% | 1.72 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 3.47% | 1.33 | |
| 15 Dec 2021 | 2.56% | 1.29 | |
| 31 Dec 2021 | 2.20% | 1.10 |
See also: Oruka Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.